One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Sincere Advice: Everyone Should Test Intestinal FloraNovember 13, 2024What Is Test Flora IntestinalTest Flora Intestinal, as the name suggests, involves analyzing the genetic information of microorganisms in the gut to assess an individual's health status and future...view
Development of Transcriptome Sequencing TechnologyApril 4, 2023Transcriptome refers to the total sum of all expressed genes in a specific cell under specific functional conditions, which includes all transcript information of a cell. Typically, transcriptome anal...view
Application of Genome Sequencing Technology in Newborn ScreeningNovember 13, 2024Newborn screening is a successful public health initiative that prevents diseases and reduces mortality through early diagnosis and disease management. In the era of precision medicine, the expansion ...view
What Is Chromosome Karyotype Analysis?April 4, 2023Chromosome karyotype analysis is a technique that traditionally involves observing the morphology of chromosomes. In recent years, fluorescence in situ hybridization technology has been used to detect...view
Microarray Platforms with Various Applications in Genetic ResearchJuly 18, 2024In recent years, the advancements in genetic research have revolutionized our understanding of the human genome. At the forefront of these developments is the Microarray Platform, a pivotal technology...view